Company Overview

Who we are

A specialist in endocrinology testing

Immunodiagnostic Systems Holdings Ltd (hereafter referred to as IDS) is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.

IDS was founded in 1977 and is a global company headquartered in the UK with around 275 employees worldwide. Our products are developed and manufactured at our facilities in Europe. We serve our customers through regional offices in Europe, the USA and Brazil. Our network of distributors work on our behalf to serve our customers throughout the rest of the world. We apply globally-binding principles to ensure that all persons working for the group of companies behave in an ethical, law-abiding manner and will continue to apply a zero tolerance approach to forced labour, slavery and human trafficking in any form, in our business and supply chain. Our Modern Slavery statement can be found here. Our Inclusion and Diversity document can be found here.

On 12 July 2021 IDS was acquired by PerkinElmer (UK) Holdings Limited, thus IDS in now proudly part of the PerkinElmer family of companies.


What we do

Meeting the growing demand for efficient specialty immunoassay testing

As a leading diagnostics company, we aim to serve the needs of clinical laboratories worldwide by developing and supplying innovative solutions. Our high quality products improve laboratory efficiency and provide fast and accurate solutions for diagnosis and therapy monitoring.

Providing innovative automation solutions

Our instrument platform, the IDS-iSYS Multi-Discipline Automated System, improves laboratory efficiency for our customers through its automated technology. The IDS-iSYS Multi-Discipline Automated System was launched in 2009 and continues to be manufactured in-house. We are dedicated to enhancing our customers’ experience by improving our technology through our development programmes.

Specialist endocrinology and complementary testing

Our immunoassay portfolio is available as a combination of tests available for use on our fully-automated IDS-iSYS Multi-Discipline Automated System, or as stand-alone manual test kits. This complete offering meets the needs of both clinical and research laboratories of all types and sizes, with their diagnostic testing requirements.

Our IDS heritage within certain endocrinology fields, including vitamin D testing, offers a solid platform on which to develop a market-leading endocrinology menu:

  • Bone Metabolism
  • Calcium Metabolism
  • CKD-MBD (Chronic Kidney Disease & Mineral Bone Disorders)
  • Fertility
  • Growth disorders
  • Hypertension

Through partnership, we will develop a broader complementary menu, extending into other clinical areas such as:

  • Allergy
  • Autoimmune
  • Infectious Diseases


Our purpose

Commitment to innovative diagnostic solutions

The growing number of patients and the spiralling socio-economic costs in healthcare drive a need for better diagnostics and treatment monitoring tools.

We are committed every day to develop and supply high quality, innovative diagnostic solutions. In partnership with laboratories, we share the common goal of providing clinicians and their patients with improved diagnostic outcomes.

Clinical and research laboratories across the world choose our high quality assays, automated solutions and expertise when diagnosing, monitoring, or researching conditions to improve outcomes and enhance patient value.